Peter Kardos

Summary

Publications

  1. pmc Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil
    Jose Luis Alvarez-Sala
    Microbiology Department, School of Medicine, Universidad Complutense, Avda Complutense s n, 28040 Madrid, Spain
    Antimicrob Agents Chemother 50:1762-7. 2006
  2. ncbi request reprint Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD
    Bartolome Celli
    Prim Care Respir J 15:139-42. 2006
  3. ncbi request reprint Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
    Peter Kardos
    Group Practice and Center for Respiratory and Sleep Medicine, Allergy, Maingau Hospital, Scheffelstrasse 2, 60318 Frankfurt am Main, Germany
    Am J Respir Crit Care Med 175:144-9. 2007
  4. pmc Tackling COPD: a multicomponent disease driven by inflammation
    Peter Kardos
    Respiratory and Sleep Medicine, Allergy Group Practice at Maingau Hospital, Frankfurt, Germany
    MedGenMed 8:54. 2006
  5. pmc Novel study design to assess the utility of the copd assessment test in a primary care setting
    Kevin Gruffydd-Jones
    Respiratory Centre of Excellence, GlaxoSmithKline, London, United Kingdom
    BMC Med Res Methodol 13:63. 2013
  6. ncbi request reprint Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma
    Bernd Brüggenjürgen
    Institute for Social Medicine, Epidemiology and Health Economics, Charite University Medical Center, Berlin, Germany
    Pharmacoeconomics 23:723-31. 2005

Collaborators

Detail Information

Publications6

  1. pmc Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil
    Jose Luis Alvarez-Sala
    Microbiology Department, School of Medicine, Universidad Complutense, Avda Complutense s n, 28040 Madrid, Spain
    Antimicrob Agents Chemother 50:1762-7. 2006
    ..Although this study does not prove that either drug is better than a placebo, cefditoren-pivoxil and the standard 10-day cefuroxime-axetil course had similar point estimates of success in acute exacerbations of chronic bronchitis...
  2. ncbi request reprint Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD
    Bartolome Celli
    Prim Care Respir J 15:139-42. 2006
  3. ncbi request reprint Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
    Peter Kardos
    Group Practice and Center for Respiratory and Sleep Medicine, Allergy, Maingau Hospital, Scheffelstrasse 2, 60318 Frankfurt am Main, Germany
    Am J Respir Crit Care Med 175:144-9. 2007
    ..The prevention of exacerbations, therefore, is an important treatment goal...
  4. pmc Tackling COPD: a multicomponent disease driven by inflammation
    Peter Kardos
    Respiratory and Sleep Medicine, Allergy Group Practice at Maingau Hospital, Frankfurt, Germany
    MedGenMed 8:54. 2006
    ..Minimizing the burden of COPD within--and potentially outside--the lung means treating patients early and addressing as many disease components as possible...
  5. pmc Novel study design to assess the utility of the copd assessment test in a primary care setting
    Kevin Gruffydd-Jones
    Respiratory Centre of Excellence, GlaxoSmithKline, London, United Kingdom
    BMC Med Res Methodol 13:63. 2013
    ..This paper discusses these challenges and the measures adopted to eliminate or minimise their impact on the study results...
  6. ncbi request reprint Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma
    Bernd Brüggenjürgen
    Institute for Social Medicine, Epidemiology and Health Economics, Charite University Medical Center, Berlin, Germany
    Pharmacoeconomics 23:723-31. 2005
    ..To compare the costs and effectiveness of adjustable maintenance dosing with budesonide/formoterol in a single inhaler versus fixed dosing in adults with asthma...